4Filing Date: Sep 24, 2026
Bio-techne
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000914190-26-000139
Total Value$403.3K
Trades4
Insiders1
Transaction Details
BAUMGARTNER ROBERT V
Director·Direct
Exercise · Acquire
Common Stock
Shares+15.94K
Price$0.00
Total Value$0
Shares Owned After62.44K
Transaction DateSep 22, 2026
BAUMGARTNER ROBERT V
Director·Direct
Tax W/H · Dispose
Common Stock
Shares-5.56K
Price$72.55
Total Value$403.3K
Shares Owned After56.88K
Transaction DateSep 22, 2026
BAUMGARTNER ROBERT V
Director·Direct
Exercise · Dispose
Stock Options (Right to Buy)Derivative
Shares-15.94K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateSep 22, 2026
Exercise Price$25.30
ExpiresOct 26, 2026
BAUMGARTNER ROBERT V
Director·Direct
Stock Options (Right to Buy)Derivative
Shares0
Price-
Total Value$0
Shares Owned After12.50K
Exercise Price$31.26
ExpiresOct 26, 2027
Holding Only
Post-Transaction Holdings
BAUMGARTNER ROBERT V · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 62.44K | +10.38K (19.94%) |
| Stock Options (Right to Buy) | 0 | -15.94K (-100.00%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-22
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: BIO-TECHNE Corp (TECH)
CIK: 0000842023
--- Reporting Owner ---
Name: BAUMGARTNER ROBERT V
CIK: 0001258704
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-22 | Code: M (Exercise of derivative)
Shares: +15,940 | Price: $0.00
Shares Owned After: 62,443 | Ownership: D (Direct)
[Transaction #2]
Security: Common Stock
Date: 2026-09-22 | Code: F (Payment of exercise/tax)
Shares: -5,559 | Price: $72.55
Total Value: $403,305.45
Shares Owned After: 56,884 | Ownership: D (Direct)
--- Derivative Transactions ---
[Transaction #1]
Security: Stock Options (Right to Buy)
Date: 2026-09-22 | Code: M (Exercise of derivative)
Shares: -15,940 | Price: $0.00
Exercise Price: $25.30
Exercisable: N/A | Expires: 2026-10-26
Shares Owned After: 0 | Ownership: D (Direct)
--- Holdings ---
[Holding #1]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
[Holding #2]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
[Holding #3]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
[Holding #4]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
[Holding #5]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
[Holding #6]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
[Holding #7]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
[Holding #8]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
[Holding #9]
Security: Stock Options (Right to Buy)
Ownership: D (Direct)
Footnotes:
[F1] The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
--- Footnotes (Complete Index) ---
F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
--- Signature ---
/s/ /s/ Andrew Nick as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed. (2026-09-24)